-
Biogen Appoints RED SVP
contractpharma
March 20, 2017
Ghosh will lead discovery and development efforts from idea through proof of concept
-
FDA warns China's Lumis over misbranded APIs
pharmafile
March 17, 2017
Chinese firm Lumis Global Pharmaceuticals became the latest to face the FDA’s ire as it was hit by a warning over its active pharmaceutical ingredient (API) facility in Hubei, China.
-
Deals this week: Sichuan Kelun Pharma, Ascendis Health, Zhuhai United Labs
pharmaceutical-technology
March 13, 2017
Chinese pharmaceutical company Sichuan Kelun Pharmaceutical intends to raise ¥800m ($115.93m) in gross proceeds through a public offering of bonds.
-
CPhI China to launch China Pharma Week
cphi-online
March 09, 2017
Expanded week of dedicated sessions and trends on the world’s second largest pharma market.
-
China to optimize approval procedures for registration of foreign drugs
en.people.cn
March 08, 2017
China is now studying on the ways to optimize approval procedures for drug registration of foreign companies, head of drug safety watchdog disclosed on Sunday.
-
BeiGene to develop $330 million biologics plant in China
pharmafile
March 08, 2017
BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the...
-
The end of China’s vaccine scandal? Some Chinese lawyers don’t think so
fiercepharma
March 08, 2017
Following up on China's high-profile vaccine scandal, a group of lawyers in the country are calling for more legislation to ensure vaccine safety.
-
China updates list of key reimbursable medicines
biospectrumasia
February 24, 2017
Inclusion on the National Reimbursement Drug List means a drug is accessible via state insurance schemes, making it affordable to people
-
STA Pharma – Changzhou site expands R&D team to 200 scientists
pharmaasia
February 13, 2017
The 10,000m2 R&D center currently has 24 standard process chemistry labs, a non GMP kilo lab, a crystallization lab and a process safety lab.
-
“China will continue to rise as a key base for global pharmaceutical manufacturing”
biospectrumasia
February 10, 2017
Dr Minzhang Chen, CEO and Senior Vice President of Process R&D and Manufacturing, STA, China